Invention Grant
US08217085B2 Methylsulfonylmethane (MSM) for treatment of drug resistant microorganisms
有权
甲基磺酰甲烷（MSM）用于治疗耐药微生物
- Patent Title: Methylsulfonylmethane (MSM) for treatment of drug resistant microorganisms
- Patent Title (中): 甲基磺酰甲烷（MSM）用于治疗耐药微生物
-
Application No.: US13399921Application Date: 2012-02-17
-
Publication No.: US08217085B2Publication Date: 2012-07-10
- Inventor: Rodney Benjamin , Jeffrey Varelman , Anthony Keller
- Applicant: Rodney Benjamin , Jeffrey Varelman , Anthony Keller
- Applicant Address: US WA Vancouver
- Assignee: Biogenic Innovations, LLC
- Current Assignee: Biogenic Innovations, LLC
- Current Assignee Address: US WA Vancouver
- Agency: Klarquist Sparkman, LLP
- Main IPC: A61K31/10
- IPC: A61K31/10
Abstract:
Embodiments of the invention relate generally to the use of compositions comprising methylsulfonylmethane (MSM), and one or more therapeutic agents, for the treatment of drug-sensitive and drug resistant microorganisms. In several embodiments, such compositions are effective in treating drug resistant infectious diseases, for example, MRSA.
Public/Granted literature
- US20120149672A1 METHYLSULFONYLMETHANE (MSM) FOR TREATMENT OF DRUG RESISTANT MICROORGANISMS Public/Granted day:2012-06-14
Information query
